Active, not recruitingPhase 1

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

NCT04521686

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Mayo Clinic of Scottsdale

Phoenix, Arizona, United States

+32 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2020-10-01
Enrollment: 200 participants
Sponsor: Eli Lilly and Company
Purpose: treatment

Locations (33)

Mayo Clinic of ScottsdalePhoenix, Arizona, United States
The University of Arizona Cancer CenterTucson, Arizona, United States
USC Norris Cancer HospitalLos Angeles, California, United States
Mayo Clinic in FloridaJacksonville, Florida, United States
University of Chicago Pritzker School of MedicineChicago, Illinois, United States
Indiana University School of MedicineIndianapolis, Indiana, United States
The John Hopkins HospitalBaltimore, Maryland, United States
Massachusetts General HospitalBoston, Massachusetts, United States
Beth Israel Deaconess Medical CenterBoston, Massachusetts, United States
Mayo ClinicRochester, Minnesota, United States
Memorial Sloan Kettering Cancer CenterMiddletown, New Jersey, United States
Memorial Sloan Kettering Cancer CenterCommack, New York, United States
Memorial Sloan Kettering Cancer CenterHarrison, New York, United States
Memorial Sloan Kettering Cancer CenterNew York, New York, United States
Sarah Cannon Cancer CenterNashville, Tennessee, United States
University of Texas MD Anderson Cancer CenterHouston, Texas, United States
South Texas Accelerated Research Therapeutics, LLCSan Antonio, Texas, United States
St Vincent's Hospital SydneyDarlinghurst, New South Wales, Australia
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud OuestBordeaux, France
Gustave RoussyVillejuif, France
Prince of Wales HospitalHong Kong, Shatin, New Territories, Hong Kong
National Cancer Center Hospital EastKashiwa, Chiba, Japan
Kanagawa Cancer CenterYokohama, Kanagawa, Japan
Osaka University HospitalSuita-shi, Osaka, Japan
Shizuoka Cancer CenterNakatogari, Shizuoka, Japan
National Cancer Center HospitalChuo-ku, Tokyo, Japan
National University HospitalSingapore, Singapore
Samsung Medical CenterSeoul, Seoul-teukbyeolsi [Seoul], South Korea
Seoul National University HospitalSeoul, South Korea
Hospital Universitario Vall d'HebronBarcelona, Spain
Hospital Universitario 12 de OctubreMadrid, Spain
China Medical University HospitalTaichung, Taiwan
National Cheng-Kung Uni. Hosp.Tainan, Taiwan